drugset / Trial / NCT01376479

Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71

NCT01376479 ↗

Phase 1 Completed 36 enrolled Inviragen Inc.
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate the safety and immune response of an inactivated vaccine to prevent hand, foot and mouth disease (HFMD) caused by Enterovirus 71 (EV71).

Timeline

Start
2011-08
Primary completion
2011-11
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject INV21 Vaccine — —